Medications for Small Cell Carcinoma Of Lung

4 results

  • imfinzi - durvalumab injection, solution

    (Durvalumab)
    Astrazeneca Pharmaceuticals Lp
    Imfinzi is a PD-L1 antibody indicated for adults with NSCLC (resectable, unresectable Stage III, or metastatic), limited- and extensive-stage SCLC, biliary tract cancer, unresectable hepatocellular carcinoma, dMMR endometrial cancer, muscle-invasive bladder cancer, and resectable gastric/GEJ adenocarcinoma. Administered as monotherapy or with chemotherapy.
    Medication Details
    Drug Interactions

  • tecentriq - atezolizumab injection, solution

    (Atezolizumab)
    Genentech, Inc.
    Tecentriq is a PD-L1 blocking antibody for treating several cancers in adults: non-small cell and small cell lung cancer, hepatocellular carcinoma, BRAF V600-positive melanoma, alveolar soft part sarcoma (including pediatric patients age 2+), and muscle invasive bladder cancer.
    Medication Details
    Drug Interactions

  • zepzelca - lurbinectedin injection, powder, lyophilized, for solution

    (Lurbinectedin)
    Jazz Pharmaceuticals, Inc.
    Zepzelca treats adults with small cell lung cancer: as maintenance therapy (with atezolizumab) for extensive-stage SCLC after first-line induction, and for metastatic SCLC that progressed on or after platinum-based chemotherapy (accelerated approval).
    Medication Details
    Drug Interactions